RLAY
HEALTHCARERelay Therapeutics Inc
AI Insight
What's Moving RLAY Today?
No stock-specific AI insight has been generated for RLAY yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$3.03$17.70
$18.64
Fundamentals
Market Cap$3.8B
P/E Ratio—
EPS$-1.56
Dividend Yield—
Dividend / Share—
ROE-40.0%
Profit Margin—
Debt / Equity—
Trading
Volume1.4M
Avg Volume (10D)—
Shares Outstanding217.9M
RLAY News
28 articles- Form 144 RELAY THERAPEUTICS For: 22 June By Investing.comInvesting.com Nigeria·Jun 23, 2026
- Relay Therapeutics Stock - Weekly review and sector context after muted news flowAD HOC NEWS·Jun 19, 2026
- Relay Therapeutics (RLAY) is One of the Best AI Driven Biotech Stocks, Here is WhyYahoo Finance·Jun 11, 2026
- What Does Breakthrough Therapy Designation Mean for Relay TherapeuticsKavout·May 30, 2026
- Relay Therapeutics to Participate in Two Upcoming Investor Conferences in JuneYahoo Finance·May 27, 2026
- Relay Therapeutics prices $275M public offering of common stock at $12/shareMSN·May 22, 2026
- Is Relay Therapeutics a Buy After Promising Trial Results?The Motley Fool·May 22, 2026
- Relay Therapeutics (RLAY) Is Up 6.9% After Follow-On Offering And Early Zovegalisib Data ReleaseYahoo Finance·May 22, 2026
- Relay Therapeutics Announces Pricing of Public Offering of Common StockYahoo Finance·May 21, 2026
- Why Relay Therapeutics Stock Popped on WednesdayMotley Fool·May 20, 2026
- Relay Therapeutics launches $175M public stock offeringMSN·May 20, 2026
- This Biotech's Drug Just Wiped The Floor With ForecastsYahoo Finance·May 19, 2026
- Relay Therapeutics Announces Proposed Public Offering of Common StockYahoo Finance·May 19, 2026
- Sector Update: Healthcare Stocks Rise Tuesday AfternoonYahoo Finance·May 19, 2026
- Rising Bond Yields Weigh on StocksBarchart·May 19, 2026
- Stocks Pressured by Tech Weakness and Rising Bond YieldsBarchart·May 19, 2026
- Relay Therapeutics shares jump after positive vascular anomalies trial results (RLAY)Advfn·May 19, 2026
- Exchange-Traded Funds, Equity Futures Edge Lower Pre-Bell Tuesday Amid Uncertainty Surrounding US-Iran TalksYahoo Finance·May 19, 2026
- Relay Therapeutics Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients with PIK3CA-Driven Vascular AnomaliesYahoo Finance·May 19, 2026
- Relay drug shows early promise against rare blood vessel diseasesBiopharmadive·May 19, 2026
- Vir Biotechnology Stock Has Nearly Doubled in a Year. One Major Holder Just Trimmed $17 MillionMotley Fool·May 18, 2026
- Thomas J. Catinazzo (RLAY) reports multiple 10b5-1 sales totaling tens of thousands of sharesStock Titan·May 14, 2026
- H.C. Wainwright is Bullish on Relay Therapeutics, Inc. (RLAY)Yahoo Finance·May 12, 2026
- How Relay’s Phase 3 Zovegalisib Breast Cancer Push Could Reshape Relay Therapeutics’ (RLAY) Investment StorySimply Wall Street·May 11, 2026
- Relay Therapeutics, Inc. (NASDAQ:RLAY) Analysts Are Cutting Their Estimates: Here's What You Need To KnowYahoo Finance·May 8, 2026
- Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 5, 2026
- Relay Therapeutics Reports First Quarter 2026 Financial Results and Corporate UpdatesYahoo Finance·May 5, 2026
- Relay Therapeutics Announces Clinical Data for Zovegalisib plus Atirmociclib Triplet Combination Supportive of Further Development in Frontline Metastatic Breast CancerGlobeNewswire Inc.·Apr 27, 2026
All 28 articles loaded
Price Data
Open$17.58
Previous Close$17.44
Day High$18.83
Day Low$17.54
52 Week High$17.70
52 Week Low$3.03
52-Week Range
$3.03$17.70
$18.64
Fundamentals
Market Cap$3.8B
P/E Ratio—
EPS$-1.56
Dividend Yield—
Dividend / Share—
ROE-40.0%
Profit Margin—
Debt / Equity—
Trading
Volume1.4M
Avg Volume (10D)—
Shares Outstanding217.9M
About Relay Therapeutics Inc
Relay Therapeutics, Inc. is a clinical-stage precision drug company. The company is headquartered in Cambridge, Massachusetts.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—